This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Complications

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The complications of this condition are based on the fact that it tends mostly to affect cells with a rapid turnover. Thus, in healthy individuals little is seen. However, the disease may precipitate an aplastic crisis in people with sickle cell anaemia, spherocytosis, or leukaemia.

Transplacental infection occurs in about 33% of cases.

There is a risk of fetal death in about 10% of cases. Adverse fetal/neonatal outcomes associated with fetal infection include:

  • risk of adverse fetal/neonatal outcomes vary with respect to gestational age at the time of infection with parvovirus:
    • if parvovirus infection occurs in the first 20 weeks of pregnancy, the risk of miscarriage rises from the 5% that a woman who is not infected with the virus has, to 15%
    • if parvovirus infection occurs in weeks 9-20, as well as the 15% risk of a miscarriage, there is also a 3% risk your baby will develop non-immune hydrops fetalis
      • hydrops fetalis is fatal in about 50% of cases
    • other possible of parvovirus infection include growth retardation, myocarditis/infarction, meconium peritonitis, placentomegaly, oedema, anaemia, rashes, thrombocytopaenia, leucopenia and respiratory insufficiency

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.